Lazaridis I, Patterson N, Mittnik A, Renaud G, Mallick S, Kirsanow K, Sudmant PH, Schraiber JG, Castellano S, Lipson M et al..  2014.  Ancient human genomes suggest three ancestral populations for present-day Europeans.. Nature. 513(7518):409-13.
Naylor MD, Karlawish JH, Arnold SE, Khachaturian AS, Khachaturian ZS, Lee VM-Y, Baumgart M, Banerjee S, Beck C, Blennow K et al..  2012.  Advancing Alzheimer's disease diagnosis, treatment, and care: recommendations from the Ware Invitational Summit.. Alzheimers Dement. 8(5):445-52.
Hodoglugil U, Mahley RW.  2012.  Turkish population structure and genetic ancestry reveal relatedness among Eurasian populations.. Ann Hum Genet. 76(2):128-41.
Chen H-K, Liu Z, Meyer-Franke A, Brodbeck J, Miranda RD, McGuire JG, Pleiss MA, Ji Z-S, Balestra ME, Walker DW et al..  2012.  Small molecule structure correctors abolish detrimental effects of apolipoprotein E4 in cultured neurons.. J Biol Chem. 287(8):5253-66.
Mahley RW, Huang Y.  2012.  Apolipoprotein e sets the stage: response to injury triggers neuropathology.. Neuron. 76(5):871-85.
Palmer ND, McDonough CW, Hicks PJ, Roh BH, Wing MR, S An S, Hester JM, Cooke JN, Bostrom MA, Rudock ME et al..  2012.  A genome-wide association search for type 2 diabetes genes in African Americans.. PLoS One. 7(1):e29202.
Dastani Z, Hivert M-F, Timpson N, Perry JRB, Yuan X, Scott RA, Henneman P, Heid IM, Kizer JR, Lyytikäinen L-P et al..  2012.  Novel loci for adiponectin levels and their influence on type 2 diabetes and metabolic traits: a multi-ethnic meta-analysis of 45,891 individuals.. PLoS Genet. 8(3):e1002607.
Brodbeck J, McGuire J, Liu Z, Meyer-Franke A, Balestra ME, Jeong D-eun, Pleiss M, McComas C, Hess F, Witter D et al..  2011.  Structure-dependent impairment of intracellular apolipoprotein E4 trafficking and its detrimental effects are rescued by small-molecule structure correctors.. J Biol Chem. 286(19):17217-26.
Hodoglugil U, Williamson DW, Yu Y, Farrer LA, Mahley RW.  2011.  Glucuronic acid epimerase is associated with plasma triglyceride and high-density lipoprotein cholesterol levels in Turks.. Ann Hum Genet. 75(3):398-417.
Chen H-K, Ji Z-S, Dodson SE, Miranda RD, Rosenblum CI, Reynolds IJ, Freedman SB, Weisgraber KH, Huang Y, Mahley RW.  2011.  Apolipoprotein E4 domain interaction mediates detrimental effects on mitochondria and is a potential therapeutic target for Alzheimer disease.. J Biol Chem. 286(7):5215-21.
Waterworth DM, Ricketts SL, Song K, Chen L, Zhao JHua, Ripatti S, Aulchenko YS, Zhang W, Yuan X, Lim N et al..  2010.  Genetic variants influencing circulating lipid levels and risk of coronary artery disease.. Arterioscler Thromb Vasc Biol. 30(11):2264-76.
Liu JZ, Tozzi F, Waterworth DM, Pillai SG, Muglia P, Middleton L, Berrettini W, Knouff CW, Yuan X, Waeber G et al..  2010.  Meta-analysis and imputation refines the association of 15q25 with smoking quantity.. Nat Genet. 42(5):436-40.
Hodoglugil U, Williamson DW, Mahley RW.  2010.  Polymorphisms in the hepatic lipase gene affect plasma HDL-cholesterol levels in a Turkish population.. J Lipid Res. 51(2):422-30.
Dupuis J, Langenberg C, Prokopenko I, Saxena R, Soranzo N, Jackson AU, Wheeler E, Glazer NL, Bouatia-Naji N, Gloyn AL et al..  2010.  New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk.. Nat Genet. 42(2):105-16.
Li G, Bien-Ly N, Andrews-Zwilling Y, Xu Q, Bernardo A, Ring K, Halabisky B, Deng C, Mahley RW, Huang Y.  2009.  GABAergic interneuron dysfunction impairs hippocampal neurogenesis in adult apolipoprotein E4 knockin mice.. Cell Stem Cell. 5(6):634-45.
J Richards B, Waterworth D, O'Rahilly S, Hivert M-F, Loos RJF, Perry JRB, Tanaka T, Timpson NJohn, Semple RK, Soranzo N et al..  2009.  A genome-wide association study reveals variants in ARL15 that influence adiponectin levels.. PLoS Genet. 5(12):e1000768.
Mahley RW, Weisgraber KH, Huang Y.  2009.  Apolipoprotein E: structure determines function, from atherosclerosis to Alzheimer's disease to AIDS.. J Lipid Res. 50 Suppl:S183-8.
Ling H, Waterworth DM, Stirnadel HA, Pollin TI, Barter PJ, Y Kesaniemi A, Mahley RW, McPherson R, Waeber G, Bersot TP et al..  2009.  Genome-wide linkage and association analyses to identify genes influencing adiponectin levels: the GEMS Study.. Obesity (Silver Spring). 17(4):737-44.
Tanyolaç S, Mahley RW, Hodoglugil U, Goldfine ID.  2008.  Gender differences in the relationship of ENPP1/PC-1 variants to obesity in a Turkish population.. Obesity (Silver Spring). 16(11):2468-71.
Burt TD, Agan BK, Marconi VC, He W, Kulkarni H, Mold JE, Cavrois MV, Huang Y, Mahley RW, Dolan MJ et al..  2008.  Apolipoprotein (apo) E4 enhances HIV-1 cell entry in vitro, and the APOE epsilon4/epsilon4 genotype accelerates HIV disease progression.. Proc Natl Acad Sci U S A. 105(25):8718-23.
Brodbeck J, Balestra ME, Saunders AM, Roses AD, Mahley RW, Huang Y.  2008.  Rosiglitazone increases dendritic spine density and rescues spine loss caused by apolipoprotein E4 in primary cortical neurons.. Proc Natl Acad Sci U S A. 105(4):1343-6.
Sandhu MS, Waterworth DM, Debenham SL, Wheeler E, Papadakis K, Zhao JHua, Song K, Yuan X, Johnson T, Ashford S et al..  2008.  LDL-cholesterol concentrations: a genome-wide association study.. Lancet. 371(9611):483-91.
Stirnadel H, Lin X, Ling H, Song K, Barter P, Y Kesaniemi A, Mahley RW, McPherson R, Waeber G, Bersot TP et al..  2008.  Genetic and phenotypic architecture of metabolic syndrome-associated components in dyslipidemic and normolipidemic subjects: the GEMS Study.. Atherosclerosis. 197(2):868-76.
Barter P, Y McPherson R, Song K, Y Kesaniemi A, Mahley RW, Waeber G, Bersot TP, Mooser V, Waterworth D, Grundy SM.  2007.  Serum insulin and inflammatory markers in overweight individuals with and without dyslipidemia.. J Clin Endocrinol Metab. 92(6):2041-5.
Roses AD, Saunders AM, Huang Y, Strum J, Weisgraber KH, Mahley RW.  2007.  Complex disease-associated pharmacogenetics: drug efficacy, drug safety, and confirmation of a pathogenetic hypothesis (Alzheimer's disease).. Pharmacogenomics J. 7(1):10-28.
Mahley RW, Huang Y, Weisgraber KH.  2007.  Detrimental effects of apolipoprotein E4: potential therapeutic targets in Alzheimer's disease.. Curr Alzheimer Res. 4(5):537-40.
Xu Q, Bernardo A, Walker D, Kanegawa T, Mahley RW, Huang Y.  2006.  Profile and regulation of apolipoprotein E (ApoE) expression in the CNS in mice with targeting of green fluorescent protein gene to the ApoE locus.. J Neurosci. 26(19):4985-94.
Mahley RW, Huang Y, Weisgraber KH.  2006.  Putting cholesterol in its place: apoE and reverse cholesterol transport.. J Clin Invest. 116(5):1226-9.
Mahley RW, Bersot TP.  2006.  High density lipoprotein cholesterol in coronary artery patients: is it as low as expected? Anadolu Kardiyol Derg. 6(1):94-6;authorreply96.
Safar JG, Wille H, Geschwind MD, Deering C, Latawiec D, Serban A, King DJ, Legname G, Weisgraber KH, Mahley RW et al..  2006.  Human prions and plasma lipoproteins.. Proc Natl Acad Sci U S A. 103(30):11312-7.
Hodoglugil U, Tanyolaç S, Williamson DW, Huang Y, Mahley RW.  2006.  Apolipoprotein A-V: a potential modulator of plasma triglyceride levels in Turks.. J Lipid Res. 47(1):144-53.
Ji Z-S, Müllendorff K, Cheng IH, R Miranda D, Huang Y, Mahley RW.  2006.  Reactivity of apolipoprotein E4 and amyloid beta peptide: lysosomal stability and neurodegeneration.. J Biol Chem. 281(5):2683-92.
Mahley RW, Weisgraber KH, Huang Y.  2006.  Apolipoprotein E4: a causative factor and therapeutic target in neuropathology, including Alzheimer's disease.. Proc Natl Acad Sci U S A. 103(15):5644-51.
Yu Y, Wyszynski DF, Waterworth DM, Wilton SD, Barter PJ, Y Kesaniemi A, Mahley RW, McPherson R, Waeber G, Bersot TP et al..  2005.  Multiple QTLs influencing triglyceride and HDL and total cholesterol levels identified in families with atherogenic dyslipidemia.. J Lipid Res. 46(10):2202-13.
Wyszynski DF, Waterworth DM, Barter PJ, Cohen J, Y Kesaniemi A, Mahley RW, McPherson R, Waeber G, Bersot TP, Sharma SS et al..  2005.  Relation between atherogenic dyslipidemia and the Adult Treatment Program-III definition of metabolic syndrome (Genetic Epidemiology of Metabolic Syndrome Project).. Am J Cardiol. 95(2):194-8.
Chang S, Ma Tran, R Miranda D, Balestra ME, Mahley RW, Huang Y.  2005.  Lipid- and receptor-binding regions of apolipoprotein E4 fragments act in concert to cause mitochondrial dysfunction and neurotoxicity.. Proc Natl Acad Sci U S A. 102(51):18694-9.
Ye S, Huang Y, Müllendorff K, Dong L, Giedt G, Meng EC, Cohen FE, Kuntz ID, Weisgraber KH, Mahley RW.  2005.  Apolipoprotein (apo) E4 enhances amyloid beta peptide production in cultured neuronal cells: apoE structure as a potential therapeutic target.. Proc Natl Acad Sci U S A. 102(51):18700-5.
Mahley RW, Can S, Ozbayrakçi S, Bersot TP, Tanir S, K Palaoğlu E, Pépin GM.  2005.  Modulation of high-density lipoproteins in a population in istanbul, Turkey, with low levels of high-density lipoproteins.. Am J Cardiol. 96(4):547-55.
Xu Q, Brecht WJ, Weisgraber KH, Mahley RW, Huang Y.  2004.  Apolipoprotein E4 domain interaction occurs in living neuronal cells as determined by fluorescence resonance energy transfer.. J Biol Chem. 279(24):25511-6.
Harris FM, Tesseur I, Brecht WJ, Xu Q, Müllendorff K, Chang S, Wyss-Coray T, Mahley RW, Huang Y.  2004.  Astroglial regulation of apolipoprotein E expression in neuronal cells. Implications for Alzheimer's disease.. J Biol Chem. 279(5):3862-8.
Shohet RV, Vega GL, Bersot TP, Mahley RW, Grundy SM, Guerra R, Cohen JC.  2002.  Sources of variability in genetic association studies: insights from the analysis of hepatic lipase (LIPC).. Hum Mutat. 19(5):536-42.
Ji Z-S, R Miranda D, Newhouse YM, Weisgraber KH, Huang Y, Mahley RW.  2002.  Apolipoprotein E4 potentiates amyloid beta peptide-induced lysosomal leakage and apoptosis in neuronal cells.. J Biol Chem. 277(24):21821-8.
Ludwig EH, Mahley RW, Palaoglu E, Ozbayrakçi S, Balestra ME, Borecki IB, Innerarity TL, Farese RV.  2002.  DGAT1 promoter polymorphism associated with alterations in body mass index, high density lipoprotein levels and blood pressure in Turkish women.. Clin Genet. 62(1):68-73.
Huang Y, Liu XQ, Wyss-Coray T, Brecht WJ, Sanan DA, Mahley RW.  2001.  Apolipoprotein E fragments present in Alzheimer's disease brains induce neurofibrillary tangle-like intracellular inclusions in neurons.. Proc Natl Acad Sci U S A. 98(15):8838-43.
Dichek HL, Johnson SM, Akeefe H, Lo GT, Sage E, Yap CE, Mahley RW.  2001.  Hepatic lipase overexpression lowers remnant and LDL levels by a noncatalytic mechanism in LDL receptor-deficient mice.. J Lipid Res. 42(2):201-10.
Mahley RW, Arslan P, Pekcan G, Pépin GM, Ağaçdiken A, Karaağoğlu N, Rakicioğlu N, Nursal B, Dayanikli P, Palaoğlu KE et al..  2001.  Plasma lipids in Turkish children: impact of puberty, socioeconomic status, and nutrition on plasma cholesterol and HDL.. J Lipid Res. 42(12):1996-2006.
Nguyen TT, Kruckeberg KE, O'Brien JF, Ji ZS, Karnes PS, Crotty TB, Hay ID, Mahley RW, O'Brien T.  2000.  Familial splenomegaly: macrophage hypercatabolism of lipoproteins associated with apolipoprotein E mutation [apolipoprotein E (delta149 Leu)].. J Clin Endocrinol Metab. 85(11):4354-8.
Mahley RW, Rall SC.  2000.  Apolipoprotein E: far more than a lipid transport protein.. Annu Rev Genomics Hum Genet. 1:507-37.
Langer C, Huang Y, Cullen P, Wiesenhütter B, Mahley RW, Assmann G, von Eckardstein A.  2000.  Endogenous apolipoprotein E modulates cholesterol efflux and cholesteryl ester hydrolysis mediated by high-density lipoprotein-3 and lipid-free apolipoproteins in mouse peritoneal macrophages.. J Mol Med (Berl). 78(4):217-27.
Orth M, Weng W, Funke H, Steinmetz A, Assmann G, Nauck M, Dierkes J, Ambrosch A, Weisgraber KH, Mahley RW et al..  1999.  Effects of a frequent apolipoprotein E isoform, ApoE4Freiburg (Leu28-->Pro), on lipoproteins and the prevalence of coronary artery disease in whites.. Arterioscler Thromb Vasc Biol. 19(5):1306-15.
Bersot TP, Vega GL, Grundy SM, Palaoğlu KE, Atagündüz P, Ozbayrakçi S, Gökdemir O, Mahley RW.  1999.  Elevated hepatic lipase activity and low levels of high density lipoprotein in a normotriglyceridemic, nonobese Turkish population.. J Lipid Res. 40(3):432-8.
Mahley RW, Huang Y.  1999.  Apolipoprotein E: from atherosclerosis to Alzheimer's disease and beyond.. Curr Opin Lipidol. 10(3):207-17.
Mahley RW, Rall SC.  1999.  Is epsilon4 the ancestral human apoE allele? Neurobiol Aging. 20(4):429-30.
Huang Y, Ji ZS, Brecht WJ, Rall SC, Taylor JM, Mahley RW.  1999.  Overexpression of apolipoprotein E3 in transgenic rabbits causes combined hyperlipidemia by stimulating hepatic VLDL production and impairing VLDL lipolysis.. Arterioscler Thromb Vasc Biol. 19(12):2952-9.
Huang Y, Liu XQ, Rall SC, Taylor JM, von Eckardstein A, Assmann G, Mahley RW.  1998.  Overexpression and accumulation of apolipoprotein E as a cause of hypertriglyceridemia.. J Biol Chem. 273(41):26388-93.
Fan J, Ji ZS, Huang Y, de Silva H, Sanan D, Mahley RW, Innerarity TL, Taylor JM.  1998.  Increased expression of apolipoprotein E in transgenic rabbits results in reduced levels of very low density lipoproteins and an accumulation of low density lipoproteins in plasma.. J Clin Invest. 101(10):2151-64.
Pitas RE, Ji ZS, Weisgraber KH, Mahley RW.  1998.  Role of apolipoprotein E in modulating neurite outgrowth: potential effect of intracellular apolipoprotein E.. Biochem Soc Trans. 26(2):257-62.
Zhu Y, Bellosta S, Langer C, Bernini F, Pitas RE, Mahley RW, Assmann G, von Eckardstein A.  1998.  Low-dose expression of a human apolipoprotein E transgene in macrophages restores cholesterol efflux capacity of apolipoprotein E-deficient mouse plasma.. Proc Natl Acad Sci U S A. 95(13):7585-90.
Vega GL, Gao J, Bersot TP, Mahley RW, Verstraete R, Grundy SM, White A, Cohen JC.  1998.  The -514 polymorphism in the hepatic lipase gene (LIPC) does not influence androgen-mediated stimulation of hepatic lipase activity.. J Lipid Res. 39(7):1520-4.
Dichek HL, Brecht W, Fan J, Ji ZS, McCormick SP, Akeefe H, Conzo L, Sanan DA, Weisgraber KH, Young SG et al..  1998.  Overexpression of hepatic lipase in transgenic mice decreases apolipoprotein B-containing and high density lipoproteins. Evidence that hepatic lipase acts as a ligand for lipoprotein uptake.. J Biol Chem. 273(4):1896-903.
Mahley RW.  1997.  The J. David Gladstone Institutes.. Mol Med. 3(9):569-71.
Huang Y, Rall SC, Mahley RW.  1997.  Genetic factors precipitating type III hyperlipoproteinemia in hypolipidemic transgenic mice expressing human apolipoprotein E2.. Arterioscler Thromb Vasc Biol. 17(11):2817-24.
Hussain MM, Goldberg IJ, Weisgraber KH, Mahley RW, Innerarity TL.  1997.  Uptake of chylomicrons by the liver, but not by the bone marrow, is modulated by lipoprotein lipase activity.. Arterioscler Thromb Vasc Biol. 17(7):1407-13.
McGeer PL, Walker DG, Pitas RE, Mahley RW, McGeer EG.  1997.  Apolipoprotein E4 (ApoE4) but not ApoE3 or ApoE2 potentiates beta-amyloid protein activation of complement in vitro.. Brain Res. 749(1):135-8.
Huang Y, Schwendner SW, Rall SC, Mahley RW.  1996.  Hypolipidemic and hyperlipidemic phenotypes in transgenic mice expressing human apolipoprotein E2.. J Biol Chem. 271(46):29146-51.
Weisgraber KH, Mahley RW.  1996.  Human apolipoprotein E: the Alzheimer's disease connection.. FASEB J. 10(13):1485-94.
Mahley RW, Nathan BP, Pitas RE.  1996.  Apolipoprotein E. Structure, function, and possible roles in Alzheimer's disease.. Ann N Y Acad Sci. 777:139-45.
Holtzman DM, Pitas RE, Kilbridge J, Nathan B, Mahley RW, Bu G, Schwartz AL.  1995.  Low density lipoprotein receptor-related protein mediates apolipoprotein E-dependent neurite outgrowth in a central nervous system-derived neuronal cell line.. Proc Natl Acad Sci U S A. 92(21):9480-4.
Bellosta S, Nathan BP, Orth M, Dong LM, Mahley RW, Pitas RE.  1995.  Stable expression and secretion of apolipoproteins E3 and E4 in mouse neuroblastoma cells produces differential effects on neurite outgrowth.. J Biol Chem. 270(45):27063-71.
Bellosta S, Mahley RW, Sanan DA, Murata J, Newland DL, Taylor JM, Pitas RE.  1995.  Macrophage-specific expression of human apolipoprotein E reduces atherosclerosis in hypercholesterolemic apolipoprotein E-null mice.. J Clin Invest. 96(5):2170-9.
Nathan BP, Chang KC, Bellosta S, Brisch E, Ge N, Mahley RW, Pitas RE.  1995.  The inhibitory effect of apolipoprotein E4 on neurite outgrowth is associated with microtubule depolymerization.. J Biol Chem. 270(34):19791-9.
Mahley RW, Nathan BP, Bellosta S, Pitas RE.  1995.  Apolipoprotein E: impact of cytoskeletal stability in neurons and the relationship to Alzheimer's disease.. Curr Opin Lipidol. 6(2):86-91.
Mahley RW, Palaoğlu KE, Atak Z, Dawson-Pepin J, Langlois AM, Cheung V, Onat H, Fulks P, Mahley LL, Vakar F.  1995.  Turkish Heart Study: lipids, lipoproteins, and apolipoproteins.. J Lipid Res. 36(4):839-59.
Dong LM, Wilson C, Wardell MR, Simmons T, Mahley RW, Weisgraber KH, Agard DA.  1994.  Human apolipoprotein E. Role of arginine 61 in mediating the lipoprotein preferences of the E3 and E4 isoforms.. J Biol Chem. 269(35):22358-65.
Mahley RW, Ji ZS, Brecht WJ, Miranda RD, He D.  1994.  Role of heparan sulfate proteoglycans and the LDL receptor-related protein in remnant lipoprotein metabolism.. Ann N Y Acad Sci. 737:39-52.
Thomas DL, Mahley RW, Badur S, Palaoglu E, Quinn TC.  1994.  The epidemiology of hepatitis C in Turkey.. Infection. 22(6):411-4.
Fazio S, Sanan DA, Lee YL, Ji ZS, Mahley RW, Rall SC.  1994.  Susceptibility to diet-induced atherosclerosis in transgenic mice expressing a dysfunctional human apolipoprotein E(Arg 112,Cys142).. Arterioscler Thromb. 14(11):1873-9.
Nathan BP, Bellosta S, Sanan DA, Weisgraber KH, Mahley RW, Pitas RE.  1994.  Differential effects of apolipoproteins E3 and E4 on neuronal growth in vitro.. Science. 264(5160):850-2.
Ji ZS, Lauer SJ, Fazio S, Bensadoun A, Taylor JM, Mahley RW.  1994.  Enhanced binding and uptake of remnant lipoproteins by hepatic lipase-secreting hepatoma cells in culture.. J Biol Chem. 269(18):13429-36.
de Silva HV, Lauer SJ, Wang J, Simonet WS, Weisgraber KH, Mahley RW, Taylor JM.  1994.  Overexpression of human apolipoprotein C-III in transgenic mice results in an accumulation of apolipoprotein B48 remnants that is corrected by excess apolipoprotein E.. J Biol Chem. 269(3):2324-35.
Fan J, Wang J, Bensadoun A, Lauer SJ, Dang Q, Mahley RW, Taylor JM.  1994.  Overexpression of hepatic lipase in transgenic rabbits leads to a marked reduction of plasma high density lipoproteins and intermediate density lipoproteins.. Proc Natl Acad Sci U S A. 91(18):8724-8.
Wilson C, Mau T, Weisgraber KH, Wardell MR, Mahley RW, Agard DA.  1994.  Salt bridge relay triggers defective LDL receptor binding by a mutant apolipoprotein.. Structure. 2(8):713-8.
Lüttmann S, von Eckardstein A, Wei W, Funke H, Köhler E, Mahley RW, Assmann G.  1994.  Electrophoretic screening for genetic variation in apolipoprotein C-III: identification of a novel apoC-III variant, apoC-III(Asp45-->Asn), in a Turkish patient.. J Lipid Res. 35(8):1431-40.
Sanan DA, Weisgraber KH, Russell SJ, Mahley RW, Huang D, Saunders A, Schmechel D, Wisniewski T, Frangione B, Roses AD.  1994.  Apolipoprotein E associates with beta amyloid peptide of Alzheimer's disease to form novel monofibrils. Isoform apoE4 associates more efficiently than apoE3.. J Clin Invest. 94(2):860-9.
Lund-Katz S, Weisgraber KH, Mahley RW, Phillips MC.  1993.  Conformation of apolipoprotein E in lipoproteins.. J Biol Chem. 268(31):23008-15.
Chiesa G, Johnson DF, Yao Z, Innerarity TL, Mahley RW, Young SG, Hammer RH, Hobbs HH.  1993.  Expression of human apolipoprotein B100 in transgenic mice. Editing of human apolipoprotein B100 mRNA.. J Biol Chem. 268(32):23747-50.
Ji ZS, Brecht WJ, Miranda RD, Hussain MM, Innerarity TL, Mahley RW.  1993.  Role of heparan sulfate proteoglycans in the binding and uptake of apolipoprotein E-enriched remnant lipoproteins by cultured cells.. J Biol Chem. 268(14):10160-7.
de Silva HV, Lauer SJ, Mahley RW, Weisgraber KH, Taylor JM.  1993.  Apolipoproteins E and C-III have opposing roles in the clearance of lipoprotein remnants in transgenic mice.. Biochem Soc Trans. 21(2):483-7.
Thomas DL, Mahley RW, Badur S, Palaoğlu KE, Quinn TC.  1993.  Epidemiology of hepatitis E virus infection in Turkey.. Lancet. 341(8860):1561-2.
Bersot TP, Russell SJ, Thatcher SR, Pomernacki NK, Mahley RW, Weisgraber KH, Innerarity TL, Fox CS.  1993.  A unique haplotype of the apolipoprotein B-100 allele associated with familial defective apolipoprotein B-100 in a Chinese man discovered during a study of the prevalence of this disorder.. J Lipid Res. 34(7):1149-54.
Schmidt EB, Illingworth DR, Bacon S, Mahley RW, Weisgraber KH.  1993.  Hypocholesterolemic effects of cholestyramine and colestipol in patients with familial defective apolipoprotein B-100.. Atherosclerosis. 98(2):213-7.
Schmidt EB, Illingworth DR, Bacon S, Russell SJ, Thatcher SR, Mahley RW, Weisgraber KH.  1993.  Hypolipidemic effects of nicotinic acid in patients with familial defective apolipoprotein B-100.. Metabolism. 42(2):137-9.
Illingworth DR, Vakar F, Mahley RW, Weisgraber KH.  1992.  Hypocholesterolaemic effects of lovastatin in familial defective apolipoprotein B-100.. Lancet. 339(8793):598-600.
Rall SC, Mahley RW.  1992.  The role of apolipoprotein E genetic variants in lipoprotein disorders.. J Intern Med. 231(6):653-9.
Wilson C, Wardell MR, Weisgraber KH, Mahley RW, Agard DA.  1991.  Three-dimensional structure of the LDL receptor-binding domain of human apolipoprotein E.. Science. 252(5014):1817-22.
Hussain MM, Maxfield FR, Más-Oliva J, Tabas I, Ji ZS, Innerarity TL, Mahley RW.  1991.  Clearance of chylomicron remnants by the low density lipoprotein receptor-related protein/alpha 2-macroglobulin receptor.. J Biol Chem. 266(21):13936-40.
Mahley RW, Weisgraber KH, Innerarity TL, Rall SC.  1991.  Genetic defects in lipoprotein metabolism. Elevation of atherogenic lipoproteins caused by impaired catabolism.. JAMA. 265(1):78-83.
Kowal RC, Herz J, Weisgraber KH, Mahley RW, Brown MS, Goldstein JL.  1990.  Opposing effects of apolipoproteins E and C on lipoprotein binding to low density lipoprotein receptor-related protein.. J Biol Chem. 265(18):10771-9.
Crook D, Weisgraber KH, Boyles JK, Mahley RW.  1990.  Isolation and characterization of plasma lipoproteins of common marmoset monkey. Comparison of effects of control and atherogenic diets.. Arteriosclerosis. 10(4):633-47.
Crook D, Weisgraber KH, Rall SC, Mahley RW.  1990.  Isolation and characterization of several plasma apolipoproteins of common marmoset monkey.. Arteriosclerosis. 10(4):625-32.
Innerarity TL, Mahley RW, Weisgraber KH, Bersot TP, Krauss RM, Vega GL, Grundy SM, Friedl W, Davignon J, McCarthy BJ.  1990.  Familial defective apolipoprotein B-100: a mutation of apolipoprotein B that causes hypercholesterolemia.. J Lipid Res. 31(8):1337-49.
Weisgraber KH, Innerarity TL, Rall SC, Mahley RW.  1990.  Atherogenic lipoproteins resulting from genetic defects of apolipoproteins B and E.. Ann N Y Acad Sci. 598:37-48.
Steinberg D, Carew TE, Fielding C, Fogelman AM, Mahley RW, Sniderman AD, Zilversmit DB.  1989.  Lipoproteins and the pathogenesis of atherosclerosis.. Circulation. 80(3):719-23.
Hussain MM, Mahley RW, Boyles JK, Lindquist PA, Brecht WJ, Innerarity TL.  1989.  Chylomicron metabolism. Chylomicron uptake by bone marrow in different animal species.. J Biol Chem. 264(30):17931-8.
Boyles JK, Zoellner CD, Anderson LJ, Kosik LM, Pitas RE, Weisgraber KH, Hui DY, Mahley RW, Gebicke-Haerter PJ, Ignatius MJ.  1989.  A role for apolipoprotein E, apolipoprotein A-I, and low density lipoprotein receptors in cholesterol transport during regeneration and remyelination of the rat sciatic nerve.. J Clin Invest. 83(3):1015-31.
Hussain MM, Mahley RW, Boyles JK, Fainaru M, Brecht WJ, Lindquist PA.  1989.  Chylomicron-chylomicron remnant clearance by liver and bone marrow in rabbits. Factors that modify tissue-specific uptake.. J Biol Chem. 264(16):9571-82.
Mahley RW, Weisgraber KH, Hussain MM, Greenman B, Fisher M, Vogel T, Gorecki M.  1989.  Intravenous infusion of apolipoprotein E accelerates clearance of plasma lipoproteins in rabbits.. J Clin Invest. 83(6):2125-30.
Weisgraber KH, Newhouse YM, Taylor JM, Tuan B, Nestruck AC, Davignon J, Mahley RW.  1989.  Apolipoprotein E2(Arg158----Cys) frequency in a hyperlipidemic French-Canadian population of apolipoprotein E2/2 subjects. Determination by synthetic oligonucleotide probes.. Arteriosclerosis. 9(1):50-7.
Mahley RW, Hui DY, Innerarity TL, Beisiegel U.  1989.  Chylomicron remnant metabolism. Role of hepatic lipoprotein receptors in mediating uptake.. Arteriosclerosis. 9(1 Suppl):I14-8.
Rall SC, Newhouse YM, Clarke HR, Weisgraber KH, McCarthy BJ, Mahley RW, Bersot TP.  1989.  Type III hyperlipoproteinemia associated with apolipoprotein E phenotype E3/3. Structure and genetics of an apolipoprotein E3 variant.. J Clin Invest. 83(4):1095-101.
Majack RA, Castle CK, Goodman LV, Weisgraber KH, Mahley RW, Shooter EM, Gebicke-Haerter PJ.  1988.  Expression of apolipoprotein E by cultured vascular smooth muscle cells is controlled by growth state.. J Cell Biol. 107(3):1207-13.
Beisiegel U, Weber W, Havinga JR, Ihrke G, Hui DY, Wernette-Hammond ME, Turck CW, Innerarity TL, Mahley RW.  1988.  Apolipoprotein E-binding proteins isolated from dog and human liver.. Arteriosclerosis. 8(3):288-97.
Koo C, Wernette-Hammond ME, Garcia Z, Malloy MJ, Uauy R, East C, Bilheimer DW, Mahley RW, Innerarity TL.  1988.  Uptake of cholesterol-rich remnant lipoproteins by human monocyte-derived macrophages is mediated by low density lipoprotein receptors.. J Clin Invest. 81(5):1332-40.
Fainaru M, Funke H, Boyles JK, Ludwig EH, Innerarity TL, Mahley RW.  1988.  Metabolism of canine beta-very low density lipoproteins in normal and cholesterol-fed dogs.. Arteriosclerosis. 8(2):130-9.
Lalazar A, Weisgraber KH, Rall SC, Giladi H, Innerarity TL, Levanon AZ, Boyles JK, Amit B, Gorecki M, Mahley RW.  1988.  Site-specific mutagenesis of human apolipoprotein E. Receptor binding activity of variants with single amino acid substitutions.. J Biol Chem. 263(8):3542-5.
Weisgraber KH, Newhouse YM, Mahley RW.  1988.  Apolipoprotein E genotyping using the polymerase chain reaction and allele-specific oligonucleotide probes.. Biochem Biophys Res Commun. 157(3):1212-7.
Weisgraber KH, Innerarity TL, Newhouse YM, Young SG, Arnold KS, Krauss RM, Vega GL, Grundy SM, Mahley RW.  1988.  Familial defective apolipoprotein B-100: enhanced binding of monoclonal antibody MB47 to abnormal low density lipoproteins.. Proc Natl Acad Sci U S A. 85(24):9758-62.
Innerarity TL, Weisgraber KH, Arnold KS, Mahley RW, Krauss RM, Vega GL, Grundy SM.  1987.  Familial defective apolipoprotein B-100: low density lipoproteins with abnormal receptor binding.. Proc Natl Acad Sci U S A. 84(19):6919-23.
Ignatius MJ, Shooter EM, Pitas RE, Mahley RW.  1987.  Lipoprotein uptake by neuronal growth cones in vitro.. Science. 236(4804):959-62.
Marcel YL, Innerarity TL, Spilman C, Mahley RW, Protter AA, Milne RW.  1987.  Mapping of human apolipoprotein B antigenic determinants.. Arteriosclerosis. 7(2):166-75.
Pitas RE, Boyles JK, Lee SH, Foss D, Mahley RW.  1987.  Astrocytes synthesize apolipoprotein E and metabolize apolipoprotein E-containing lipoproteins.. Biochim Biophys Acta. 917(1):148-61.
Gebicke-Haerter PJ, Darby JK, Shooter EM, Riccardi VM, Weisgraber KH, Boyles JK, Mahley RW.  1987.  Apolipoprotein E synthesis in neurofibrosarcoma and schwannoma cell cultures from two individuals with neurofibromatosis.. Exp Neurol. 95(2):323-35.
Corsini A, Spilman CH, Innerarity TL, Arnold KS, Rall SC, Boyles JK, Mahley RW.  1987.  Receptor binding activity of lipid recombinants of apolipoprotein B-100 thrombolytic fragments.. J Lipid Res. 28(12):1410-23.
Innerarity TL, Young SG, Poksay KS, Mahley RW, Smith RS, Milne RW, Marcel YL, Weisgraber KH.  1987.  Structural relationship of human apolipoprotein B48 to apolipoprotein B100.. J Clin Invest. 80(6):1794-8.
Friedman G, Wernette-Hammond ME, Hui DY, Mahley RW, Innerarity TL.  1987.  Characterization of lipoprotein receptors on rat Fu5AH hepatoma cells.. J Lipid Res. 28(12):1482-94.
Ludwig EH, Blackhart BD, Pierotti VR, Caiati L, Fortier C, Knott T, Scott J, Mahley RW, Levy-Wilson B, McCarthy BJ.  1987.  DNA sequence of the human apolipoprotein B gene.. DNA. 6(4):363-72.
Scott J, Pease RJ, Powell LM, Wallis SC, McCarthy BJ, Mahley RW, Levy-Wilson B, Knott TJ.  1987.  Human apolipoprotein B: complete cDNA sequence and identification of structural domains of the protein.. Biochem Soc Trans. 15(2):195-9.
Scott J, Pease RJ, Powell LM, Wallis SC, McCarthy BJ, Mahley RW, Levy-Wilson B, Knott TJ.  1987.  Apolipoprotein B gene: plasma cholesterol and atherosclerosis.. Biochem Soc Symp. 53:155-63.
Innerarity TL, Weisgraber KH, Rall SC, Mahley RW.  1987.  Functional domains of apolipoprotein E and apolipoprotein B.. Acta Med Scand Suppl. 715:51-9.
Knott TJ, Wallis SC, Powell LM, Pease RJ, Lusis AJ, Blackhart B, McCarthy BJ, Mahley RW, Levy-Wilson B, Scott J.  1986.  Complete cDNA and derived protein sequence of human apolipoprotein B-100.. Nucleic Acids Res. 14(18):7501-3.
Mahley RW, Innerarity TL, Hui DY, Weisgraber KH, Pitas RE.  1986.  Pathology: plasma cholesterol levels determined by lipoprotein interactions with cell surface receptors.. West J Med. 145(3):372.
Hui DY, Brecht WJ, Hall EA, Friedman G, Innerarity TL, Mahley RW.  1986.  Isolation and characterization of the apolipoprotein E receptor from canine and human liver.. J Biol Chem. 261(9):4256-67.
Reardon CA, Lau YF, Paik YK, Weisgraber KH, Mahley RW, Taylor JM.  1986.  Expression of the human apolipoprotein E gene in cultured mammalian cells.. J Biol Chem. 261(21):9858-64.
Innerarity TL, Arnold KS, Weisgraber KH, Mahley RW.  1986.  Apolipoprotein E is the determinant that mediates the receptor uptake of beta-very low density lipoproteins by mouse macrophages.. Arteriosclerosis. 6(1):114-22.
Weisgraber KH, Rall SC, Mahley RW, Milne RW, Marcel YL, Sparrow JT.  1986.  Human apolipoprotein E. Determination of the heparin binding sites of apolipoprotein E3.. J Biol Chem. 261(5):2068-76.
Ignatius MJ, Gebicke-Härter PJ, Skene JH, Schilling JW, Weisgraber KH, Mahley RW, Shooter EM.  1986.  Expression of apolipoprotein E during nerve degeneration and regeneration.. Proc Natl Acad Sci U S A. 83(4):1125-9.
Bersot TP, Innerarity TL, Pitas RE, Rall SC, Weisgraber KH, Mahley RW.  1986.  Fat feeding in humans induces lipoproteins of density less than 1.006 that are enriched in apolipoprotein [a] and that cause lipid accumulation in macrophages.. J Clin Invest. 77(2):622-30.
Rall SC, Weisgraber KH, Mahley RW, Ehnholm C, Schamaun O, Olaisen B, Blomhoff JP, Teisberg P.  1986.  Identification of homozygosity for a human apolipoprotein A-I variant.. J Lipid Res. 27(4):436-41.
Innerarity TL, Hui DY, Bersot TP, Mahley RW.  1986.  Type III hyperlipoproteinemia: a focus on lipoprotein receptor-apolipoprotein E2 interactions.. Adv Exp Med Biol. 201:273-88.
Rall SC, Weisgraber KH, Mahley RW.  1986.  Isolation and characterization of apolipoprotein E.. Methods Enzymol. 128:273-87.
Taylor JM, Mahley RW, Fukazawa C.  1986.  Cloning of the cDNA for rat and human apolipoprotein E mRNA.. Methods Enzymol. 128:801-11.
Weisgraber KH, Mahley RW.  1986.  Characterization of apolipoprotein E-containing lipoproteins.. Methods Enzymol. 129:145-66.
Reardon CA, Paik YK, Chang DJ, Davies GE, Mahley RW, Lau YF, Taylor JM.  1986.  Cloning and expression of the human apolipoprotein E gene.. Methods Enzymol. 128:811-23.
Innerarity TL, Pitas RE, Mahley RW.  1986.  Lipoprotein-receptor interactions.. Methods Enzymol. 129:542-65.
Mahley RW, Innerarity TL, Weisgraber KH, Rall SC, Hui DY, Lalazar A, Boyles JK, Taylor JM, Levy-Wilson B.  1986.  Cellular and molecular biology of lipoprotein metabolism: characterization of lipoprotein receptor-ligand interactions.. Cold Spring Harb Symp Quant Biol. 51 Pt 2:821-8.
Cornhill JF, Barrett WA, Herderick EE, Mahley RW, Fry DL.  1985.  Topographic study of sudanophilic lesions in cholesterol-fed minipigs by image analysis.. Arteriosclerosis. 5(5):415-26.
Boyles JK, Pitas RE, Wilson E, Mahley RW, Taylor JM.  1985.  Apolipoprotein E associated with astrocytic glia of the central nervous system and with nonmyelinating glia of the peripheral nervous system.. J Clin Invest. 76(4):1501-13.
Paik YK, Chang DJ, Reardon CA, Davies GE, Mahley RW, Taylor JM.  1985.  Nucleotide sequence and structure of the human apolipoprotein E gene.. Proc Natl Acad Sci U S A. 82(10):3445-9.
Pitas RE, Boyles J, Mahley RW, Bissell DM.  1985.  Uptake of chemically modified low density lipoproteins in vivo is mediated by specific endothelial cells.. J Cell Biol. 100(1):103-17.
Weisgraber KH, Newhouse YM, Seymour JL, Rall SC, Mahley RW.  1985.  Preparative immobiline isoelectric focusing of plasma apolipoproteins on vertical slab gels.. Anal Biochem. 151(2):455-61.
Weisgraber KH, Innerarity TL, Rall SC, Mahley RW.  1985.  Receptor interactions controlling lipoprotein metabolism.. Can J Biochem Cell Biol. 63(8):898-905.
Mahley RW, Innerarity TL, Rall SC, Weisgraber KH.  1985.  Lipoproteins of special significance in atherosclerosis. Insights provided by studies of type III hyperlipoproteinemia.. Ann N Y Acad Sci. 454:209-21.
Weisgraber KH, Innerarity TL, Rall SC, Mahley RW.  1985.  Apolipoprotein E: receptor binding properties.. Adv Exp Med Biol. 183:159-71.
Funke H, Boyles J, Weisgraber KH, Ludwig EH, Hui DY, Mahley RW.  1984.  Uptake of apolipoprotein E-containing high density lipoproteins by hepatic parenchymal cells.. Arteriosclerosis. 4(5):452-61.
Ehnholm C, Mahley RW, Chappell DA, Weisgraber KH, Ludwig E, Witztum JL.  1984.  Role of apolipoprotein E in the lipolytic conversion of beta-very low density lipoproteins to low density lipoproteins in type III hyperlipoproteinemia.. Proc Natl Acad Sci U S A. 81(17):5566-70.
Utermann G, Haas J, Steinmetz A, Paetzold R, Rall SC, Weisgraber KH, Mahley RW.  1984.  Apolipoprotein A-IGiessen (Pro143----Arg). A mutant that is defective in activating lecithin:cholesterol acyltransferase.. Eur J Biochem. 144(2):325-31.
McLean JW, Elshourbagy NA, Chang DJ, Mahley RW, Taylor JM.  1984.  Human apolipoprotein E mRNA. cDNA cloning and nucleotide sequencing of a new variant.. J Biol Chem. 259(10):6498-504.
Menzel HJ, Assmann G, Rall SC, Weisgraber KH, Mahley RW.  1984.  Human apolipoprotein A-I polymorphism. Identification of amino acid substitutions in three electrophoretic variants of the Münster-3 type.. J Biol Chem. 259(5):3070-6.
Innerarity TL, Weisgraber KH, Arnold KS, Rall SC, Mahley RW.  1984.  Normalization of receptor binding of apolipoprotein E2. Evidence for modulation of the binding site conformation.. J Biol Chem. 259(11):7261-7.
Innerarity TL, Bersot TP, Arnold KS, Weisgraber KH, Davis PA, Forte TM, Mahley RW.  1984.  Receptor binding activity of high-density lipoproteins containing apoprotein E from abetalipoproteinemic and normal neonate plasma.. Metabolism. 33(2):186-95.
Mahley RW, Innerarity TL, Rall SC, Weisgraber KH.  1984.  Plasma lipoproteins: apolipoprotein structure and function.. J Lipid Res. 25(12):1277-94.
Rall SC, Weisgraber KH, Mahley RW, Ogawa Y, Fielding CJ, Utermann G, Haas J, Steinmetz A, Menzel HJ, Assmann G.  1984.  Abnormal lecithin:cholesterol acyltransferase activation by a human apolipoprotein A-I variant in which a single lysine residue is deleted.. J Biol Chem. 259(16):10063-70.
Weisgraber KH, Rall SC, Innerarity TL, Mahley RW, Kuusi T, Ehnholm C.  1984.  A novel electrophoretic variant of human apolipoprotein E. Identification and characterization of apolipoprotein E1.. J Clin Invest. 73(4):1024-33.
Steinmetz A, Utermann G, Haas J, Menzel HJ, Rall SC, Weisgraber KH, Mahley RW.  1984.  Mutations of apolipoprotein AI can affect cofactor function for cholesteryl ester formation by lecithin: cholesterol acyltransferase.. Agents Actions Suppl. 16:217-24.
Innerarity TL, Friedlander EJ, Rall SC, Weisgraber KH, Mahley RW.  1983.  The receptor-binding domain of human apolipoprotein E. Binding of apolipoprotein E fragments.. J Biol Chem. 258(20):12341-7.
Weisgraber KH, Innerarity TL, Harder KJ, Mahley RW, Milne RW, Marcel YL, Sparrow JT.  1983.  The receptor-binding domain of human apolipoprotein E. Monoclonal antibody inhibition of binding.. J Biol Chem. 258(20):12348-54.
Rall SC, Weisgraber KH, Innerarity TL, Bersot TP, Mahley RW, Blum CB.  1983.  Identification of a new structural variant of human apolipoprotein E, E2(Lys146 leads to Gln), in a type III hyperlipoproteinemic subject with the E3/2 phenotype.. J Clin Invest. 72(4):1288-97.
Schmitz G, Assmann G, Rall SC, Mahley RW.  1983.  Tangier disease: defective recombination of a specific Tangier apolipoprotein A-I isoform (pro-apo A-i) with high density lipoproteins.. Proc Natl Acad Sci U S A. 80(19):6081-5.
Gordon V, Innerarity TL, Mahley RW.  1983.  Formation of cholesterol- and apoprotein E-enriched high density lipoproteins in vitro.. J Biol Chem. 258(10):6202-12.
Mahley RW, Innerarity TL.  1983.  Lipoprotein receptors and cholesterol homeostasis.. Biochim Biophys Acta. 737(2):197-222.
Mahley RW.  1983.  Apolipoprotein E and cholesterol metabolism.. Klin Wochenschr. 61(5):225-32.
Rouleau JL, Parmley WW, Stevens J, Wikman-Coffelt J, Sievers R, Mahley RW, Havel RJ.  1983.  Verapamil suppresses atherosclerosis in cholesterol-fed rabbits.. J Am Coll Cardiol. 1(6):1453-60.
Weisgraber KH, Rall SC, Bersot TP, Mahley RW, Franceschini G, Sirtori CR.  1983.  Apolipoprotein A-IMilano. Detection of normal A-I in affected subjects and evidence for a cysteine for arginine substitution in the variant A-I.. J Biol Chem. 258(4):2508-13.
Rall SC, Weisgraber KH, Innerarity TL, Mahley RW.  1983.  Identical structural and receptor binding defects in apolipoprotein E2 in hypo-, normo-, and hypercholesterolemic dysbetalipoproteinemia.. J Clin Invest. 71(4):1023-31.
Reitman JS, Mahley RW, Fry DL.  1982.  Yucatan miniature swine as a model for diet-induced atherosclerosis.. Atherosclerosis. 43(1):119-32.
Zannis VI, Breslow JL, Utermann G, Mahley RW, Weisgraber KH, Havel RJ, Goldstein JL, Brown MS, Schonfeld G, Hazzard WR et al..  1982.  Proposed nomenclature of apoE isoproteins, apoE genotypes, and phenotypes.. J Lipid Res. 23(6):911-4.
Rall SC, Weisgraber KH, Innerarity TL, Mahley RW.  1982.  Structural basis for receptor binding heterogeneity of apolipoprotein E from type III hyperlipoproteinemic subjects.. Proc Natl Acad Sci U S A. 79(15):4696-700.
Rall SC, Weisgraber KH, Mahley RW.  1982.  Human apolipoprotein E. The complete amino acid sequence.. J Biol Chem. 257(8):4171-8.
Weisgraber KH, Rall SC, Mahley RW.  1981.  Human E apoprotein heterogeneity. Cysteine-arginine interchanges in the amino acid sequence of the apo-E isoforms.. J Biol Chem. 256(17):9077-83.
Schneider WJ, Kovanen PT, Brown MS, Goldstein JL, Utermann G, Weber W, Havel RJ, Kotite L, Kane JP, Innerarity TL et al..  1981.  Familial dysbetalipoproteinemia. Abnormal binding of mutant apoprotein E to low density lipoprotein receptors of human fibroblasts and membranes from liver and adrenal of rats, rabbits, and cows.. J Clin Invest. 68(4):1075-85.
Mahley RW, Hui DY, Innerarity TL, Weisgraber KH.  1981.  Two independent lipoprotein receptors on hepatic membranes of dog, swine, and man. Apo-B,E and apo-E receptors.. J Clin Invest. 68(5):1197-206.
Pitas RE, Innerarity TL, Weinstein JN, Mahley RW.  1981.  Acetoacetylated lipoproteins used to distinguish fibroblasts from macrophages in vitro by fluorescence microscopy.. Arteriosclerosis. 1(3):177-85.
Melchior GW, Mahley RW, Buckhold DK.  1981.  Chylomicron metabolism during dietary-induced hypercholesterolemia in dogs.. J Lipid Res. 22(4):598-609.
Hui DY, Innerarity TL, Mahley RW.  1981.  Lipoprotein binding to canine hepatic membranes. Metabolically distinct apo-E and apo-B,E receptors.. J Biol Chem. 256(11):5646-55.
Innerarity TL, Kempner ES, Hui DY, Mahley RW.  1981.  Functional unit of the low density lipoprotein receptor of fibroblasts: a 100,000-dalton structure with multiple binding sites.. Proc Natl Acad Sci U S A. 78(7):4378-82.
Fry DL, Mahley RW, Oh SY, Swyt CR.  1981.  Aortic transmural serum protein transport: effect of concentration, time, and location.. Am J Physiol. 240(1):H54-61.
Fry DL, Mahley RW, Oh SY.  1981.  Effect of arterial stretch on transmural albumin and Evan's blue dye transport.. Am J Physiol. 240(4):H645-9.
Mahley RW.  1981.  Cellular and molecular biology of lipoprotein metabolism in atherosclerosis.. Diabetes. 30(Suppl 2):60-5.
Weisgraber KH, Bersot TP, Mahley RW, Franceschini G, Sirtori CR.  1980.  A-Imilano apoprotein. Isolation and characterization of a cysteine-containing variant of the A-I apoprotein from human high density lipoproteins.. J Clin Invest. 66(5):901-7.
Mahley RW, Innerarity TL, Brown MS, Ho YK, Goldstein JL.  1980.  Cholesteryl ester synthesis in macrophages: stimulation by beta-very low density lipoproteins from cholesterol-fed animals of several species.. J Lipid Res. 21(8):970-80.
Weisgraber KH, Mahley RW.  1980.  Subfractionation of human high density lipoproteins by heparin-Sepharose affinity chromatography.. J Lipid Res. 21(3):316-25.
Weisgraber KH, Troxler RF, Rall SC, Mahley RW.  1980.  Comparison of the human, canine and swine E apoproteins.. Biochem Biophys Res Commun. 95(1):374-80.
Mahley RW, Weisgraber KH, Melchior GW, Innerarity TL, Holcombe KS.  1980.  Inhibition of receptor-mediated clearance of lysine and arginine-modified lipoproteins from the plasma of rats and monkeys.. Proc Natl Acad Sci U S A. 77(1):225-9.
Mahley RW, Johnson DK, Pucak GJ, Fry DL.  1980.  Atherosclerosis in the Erythrocebus patas, an old world monkey.. Am J Pathol. 98(2):401-24.
Hui DY, Harmony JA, Innerarity TL, Mahley RW.  1980.  Immunoregulatory plasma lipoproteins. Role of apoprotein E and apoprotein B.. J Biol Chem. 255(24):11775-81.
Fry DL, Mahley RW, Oh SY, Lewis SJ, Plowman F, Swyt CR.  1980.  Quantitative microautoradiography of arteries: comparison of radioactivity to silver.. Am J Physiol. 239(2):H289-95.
Mahley RW, Innerarity TL, Weisgraber KH.  1980.  Alterations in metabolic activity of plasma lipoproteins following selective chemical modification of the apoproteins.. Ann N Y Acad Sci. 348:265-80.
Mahley RW, Weisgraber KH, Innerarity TL.  1979.  Interaction of plasma lipoproteins containing apolipoproteins B and E with heparin and cell surface receptors.. Biochim Biophys Acta. 575(1):81-91.
Pitas RE, Nelson GJ, Jaffe RM, Mahley RW.  1979.  Effects of diets high in saturated fat and cholesterol on the lipid composition of canine platelets.. Lipids. 14(5):469-77.
Reitman JS, Mahley RW.  1979.  Changes induced in the lipoproteins of Yucatan miniature swine by cholesterol feeding.. Biochim Biophys Acta. 575(3):446-57.
Mahley RW, Innerarity TL, Bersot TP, Lipson A, Margolis S.  1978.  Alterations in human high-density lipoproteins, with or without increased plasma-cholesterol, induced by diets high in cholesterol.. Lancet. 2(8094):807-9.
Weisgraber KH, Innerarity TL, Mahley RW.  1978.  Role of lysine residues of plasma lipoproteins in high affinity binding to cell surface receptors on human fibroblasts.. J Biol Chem. 253(24):9053-62.
Mahley RW, Innerarity TL, Pitas RE, Weisgraber KH, Brown JH, Gross E.  1977.  Inhibition of lipoprotein binding to cell surface receptors of fibroblasts following selective modification of arginyl residues in arginine-rich and B apoproteins.. J Biol Chem. 252(20):7279-87.
Tall AR, Atkinson D, Small DM, Mahley RW.  1977.  Characterization of the lipoproteins of atherosclerotic swine.. J Biol Chem. 252(20):7288-93.
Mahley RW, Holcombe KS.  1977.  Alterations of the plasma lipoproteins and apoproteins following cholesterol feeding in the rat.. J Lipid Res. 18(3):314-24.
Fry DL, Mahley RW, Weisgraber KH, Oh SY.  1977.  Simultaneous accumulation of Evans blue dye and albumin in the canine aortic wall.. Am J Physiol. 233(1):H66-79.
Mahley RW, Innerarity TL, Weisgraber KH, Fry DL.  1977.  Canine hyperlipoproteinemia and atherosclerosis. Accumulation of lipid by aortic medial cells in vivo and in vitro.. Am J Pathol. 87(1):205-26.
Mahley RW, Weisgraber KH, Innerarity T, Brewer HB.  1976.  Characterization of the plasma lipoproteins and apoproteins of the Erythrocebus patas monkey.. Biochemistry. 15(9):1928-33.
Mahley RW, Nelson AW, Ferrans VJ, Fry DL.  1976.  Thrombosis in association with atherosclerosis induced by dietary perturbations in dogs.. Science. 192(4244):1139-41.
Mahley RW, Weisgraber KH, Innerarity T.  1976.  Atherogenic hyperlipoproteinemia induced by cholesterol feeding the Patas monkey.. Biochemistry. 15(14):2979-85.
Bersot TP, Mahley RW, Brown MS, Goldstein JL.  1976.  Interaction of swine lipoproteins with the low density lipoprotein receptor in human fibroblasts.. J Biol Chem. 251(8):2395-8.
Mahley RW, Weisgraber KH, Innerarity T, Brewer HB, Assmann G.  1975.  Swine lipoproteins and atherosclerosis. Changes in the plasma lipoproteins and apoproteins induced by cholesterol feeding.. Biochemistry. 14(13):2817-23.
Mahley RW, Weisgraber KH.  1974.  An electrophoretic method for the quantitative isolation of human and swine plasma lipoproteins.. Biochemistry. 13(9):1964-9.
Assmann G, Mahley RW, Davis B, Holcombe KS.  1974.  Cholesterol esterification by the rat liver Golgi apparatus.. Scand J Clin Lab Invest Suppl. 137:23-8.
Mahley RW, Gray ME, LeQuire VS.  1972.  Role of plasma lipoproteins in cortisone-induced fat embolism.. Am J Pathol. 66(1):43-64.
Mahley RW, Bennett BD, Morré DJ, Gray ME, Thistlethwaite W, LeQuire VS.  1971.  Lipoproteins associated with the Golgi apparatus isolated from epithelial cells of rat small intestine.. Lab Invest. 25(5):435-44.
Morré DJ, Hamilton RL, Mollenhauer HH, Mahley RW, Cunningham WP, Cheetham RD, LeQuire VS.  1970.  Isolation of a Golgi apparatus-rich fraction from rat liver. I. Method and morphology.. J Cell Biol. 44(3):484-91.
Mahley RW, Bersot TP, LeQuire VS, Levy RI, Windmueller HG, Brown WV.  1970.  Identity of very low density lipoprotein apoproteins of plasma and liver Golgi apparatus.. Science. 168(3929):380-2.
Engel E, Culbertson JC, Mahley RW, Fenichel GM.  1970.  Barr body studies from the hair.. Lancet. 1(7650):789.
Mahley RW, Hamilton RL, LeQuire VS.  1969.  Characterization of lipoprotein particles isolated from the Golgi apparatus of rat liver.. J Lipid Res. 10(4):433-9.

Orr AL, Kim C, Jimenez-Morales D, Newton BW, Johnson JR, Krogan NJ, Swaney DL, Mahley RW. Neuronal Apolipoprotein E4 Expression Results in Proteome-Wide Alterations and Compromises Bioenergetic Capacity by Disrupting Mitochondrial Function. J Alzheimers Dis. 2019 Mar 11.

Mahley RW. Apolipoprotein E: Remarkable Protein Sheds Light on Cardiovascular and Neurological Diseases. Clin Chem. 2017 Jan; 63(1):14-20.

Mallick S, Li H, Lipson M, Mathieson I, Gymrek M, Racimo F, Zhao M, Chennagiri N, Nordenfelt S, Tandon A, Skoglund P, Lazaridis I, Sankararaman S, Fu Q, Rohland N, Renaud G, Erlich Y, Willems T, Gallo C, Spence JP, Song YS, Poletti G, Balloux F, van Driem G, de Knijff P, Romero IG, Jha AR, Behar DM, Bravi CM, Capelli C, Hervig T, Moreno-Estrada A, Posukh OL, Balanovska E, Balanovsky O, Karachanak-Yankova S, Sahakyan H, Toncheva D, Yepiskoposyan L, Tyler-Smith C, Xue Y, Abdullah MS, Ruiz-Linares A, Beall CM, Di Rienzo A, Jeong C, Starikovskaya EB, Metspalu E, Parik J, Villems R, Henn BM, Hodoglugil U, Mahley R, Sajantila A, Stamatoyannopoulos G, Wee JT, Khusainova R, Khusnutdinova E, Litvinov S, Ayodo G, Comas D, Hammer MF, Kivisild T, Klitz W, Winkler CA, Labuda D, Bamshad M, Jorde LB, Tishkoff SA, Watkins WS, Metspalu M, Dryomov S, Sukernik R, Singh L, Thangaraj K, Pääbo S, Kelso J, Patterson N, Reich D. The Simons Genome Diversity Project: 300 genomes from 142 diverse populations. Nature. 2016 Oct 13; 538(7624):201-206.

Mahley RW. Apolipoprotein E: from cardiovascular disease to neurodegenerative disorders. J Mol Med (Berl). 2016 07; 94(7):739-46.

Mahley RW. Central Nervous System Lipoproteins: ApoE and Regulation of Cholesterol Metabolism. Arterioscler Thromb Vasc Biol. 2016 07; 36(7):1305-15.

Lazaridis I, Patterson N, Mittnik A, Renaud G, Mallick S, Kirsanow K, Sudmant PH, Schraiber JG, Castellano S, Lipson M, Berger B, Economou C, Bollongino R, Fu Q, Bos KI, Nordenfelt S, Li H, de Filippo C, Prüfer K, Sawyer S, Posth C, Haak W, Hallgren F, Fornander E, Rohland N, Delsate D, Francken M, Guinet JM, Wahl J, Ayodo G, Babiker HA, Bailliet G, Balanovska E, Balanovsky O, Barrantes R, Bedoya G, Ben-Ami H, Bene J, Berrada F, Bravi CM, Brisighelli F, Busby GB, Cali F, Churnosov M, Cole DE, Corach D, Damba L, van Driem G, Dryomov S, Dugoujon JM, Fedorova SA, Gallego Romero I, Gubina M, Hammer M, Henn BM, Hervig T, Hodoglugil U, Jha AR, Karachanak-Yankova S, Khusainova R, Khusnutdinova E, Kittles R, Kivisild T, Klitz W, Kucinskas V, Kushniarevich A, Laredj L, Litvinov S, Loukidis T, Mahley RW, Melegh B, Metspalu E, Molina J, Mountain J, Näkkäläjärvi K, Nesheva D, Nyambo T, Osipova L, Parik J, Platonov F, Posukh O, Romano V, Rothhammer F, Rudan I, Ruizbakiev R, Sahakyan H, Sajantila A, Salas A, Starikovskaya EB, Tarekegn A, Toncheva D, Turdikulova S, Uktveryte I, Utevska O, Vasquez R, Villena M, Voevoda M, Winkler CA, Yepiskoposyan L, Zalloua P, Zemunik T, Cooper A, Capelli C, Thomas MG, Ruiz-Linares A, Tishkoff SA, Singh L, Thangaraj K, Villems R, Comas D, Sukernik R, Metspalu M, Meyer M, Eichler EE, Burger J, Slatkin M, Pääbo S, Kelso J, Reich D, Krause J. Ancient human genomes suggest three ancestral populations for present-day Europeans. Nature. 2014 Sep 18; 513(7518):409-13.

Huang Y, Mahley RW. Apolipoprotein E: structure and function in lipid metabolism, neurobiology, and Alzheimer's diseases. Neurobiol Dis. 2014 Dec; 72 Pt A:3-12.

Mahley RW. Shinya Yamanaka, M.D., Ph.D. - 2012 Nobel Prize Laureate: how his dream of a research career provides vision for the next generation of young scientists. Anadolu Kardiyol Derg. 2013 May; 13(3):204-6.

Mahley RW, Huang Y. Apolipoprotein e sets the stage: response to injury triggers neuropathology. Neuron. 2012 Dec 06; 76(5):871-85.

Mahley RW, Huang Y. Small-molecule structure correctors target abnormal protein structure and function: structure corrector rescue of apolipoprotein E4-associated neuropathology. J Med Chem. 2012 Nov 08; 55(21):8997-9008.

Naylor MD, Karlawish JH, Arnold SE, Khachaturian AS, Khachaturian ZS, Lee VM, Baumgart M, Banerjee S, Beck C, Blennow K, Brookmeyer R, Brunden KR, Buckwalter KC, Comer M, Covinsky K, Feinberg LF, Frisoni G, Green C, Guimaraes RM, Gwyther LP, Hefti FF, Hutton M, Kawas C, Kent DM, Kuller L, Langa KM, Mahley RW, Maslow K, Masters CL, Meier DE, Neumann PJ, Paul SM, Petersen RC, Sager MA, Sano M, Schenk D, Soares H, Sperling RA, Stahl SM, van Deerlin V, Stern Y, Weir D, Wolk DA, Trojanowski JQ. Advancing Alzheimer's disease diagnosis, treatment, and care: recommendations from the Ware Invitational Summit. Alzheimers Dement. 2012 Sep; 8(5):445-52.

Dastani Z, Hivert MF, Timpson N, Perry JR, Yuan X, Scott RA, Henneman P, Heid IM, Kizer JR, Lyytikäinen LP, Fuchsberger C, Tanaka T, Morris AP, Small K, Isaacs A, Beekman M, Coassin S, Lohman K, Qi L, Kanoni S, Pankow JS, Uh HW, Wu Y, Bidulescu A, Rasmussen-Torvik LJ, Greenwood CM, Ladouceur M, Grimsby J, Manning AK, Liu CT, Kooner J, Mooser VE, Vollenweider P, Kapur KA, Chambers J, Wareham NJ, Langenberg C, Frants R, Willems-Vandijk K, Oostra BA, Willems SM, Lamina C, Winkler TW, Psaty BM, Tracy RP, Brody J, Chen I, Viikari J, Kähönen M, Pramstaller PP, Evans DM, St Pourcain B, Sattar N, Wood AR, Bandinelli S, Carlson OD, Egan JM, Böhringer S, van Heemst D, Kedenko L, Kristiansson K, Nuotio ML, Loo BM, Harris T, Garcia M, Kanaya A, Haun M, Klopp N, Wichmann HE, Deloukas P, Katsareli E, Couper DJ, Duncan BB, Kloppenburg M, Adair LS, Borja JB, Wilson JG, Musani S, Guo X, Johnson T, Semple R, Teslovich TM, Allison MA, Redline S, Buxbaum SG, Mohlke KL, Meulenbelt I, Ballantyne CM, Dedoussis GV, Hu FB, Liu Y, Paulweber B, Spector TD, Slagboom PE, Ferrucci L, Jula A, Perola M, Raitakari O, Florez JC, Salomaa V, Eriksson JG, Frayling TM, Hicks AA, Lehtimäki T, Smith GD, Siscovick DS, Kronenberg F, van Duijn C, Loos RJ, Waterworth DM, Meigs JB, Dupuis J, Richards JB, Voight BF, Scott LJ, Steinthorsdottir V, Dina C, Welch RP, Zeggini E, Huth C, Aulchenko YS, Thorleifsson G, McCulloch LJ, Ferreira T, Grallert H, Amin N, Wu G, Willer CJ, Raychaudhuri S, McCarroll SA, Hofmann OM, Segrè AV, van Hoek M, Navarro P, Ardlie K, Balkau B, Benediktsson R, Bennett AJ, Blagieva R, Boerwinkle E, Bonnycastle LL, Boström KB, Bravenboer B, Bumpstead S, Burtt NP, Charpentier G, Chines PS, Cornelis M, Crawford G, Doney AS, Elliott KS, Elliott AL, Erdos MR, Fox CS, Franklin CS, Ganser M, Gieger C, Grarup N, Green T, Griffin S, Groves CJ, Guiducci C, Hadjadj S, Hassanali N, Herder C, Isomaa B, Jackson AU, Johnson PR, Jørgensen T, Kao WH, Kong A, Kraft P, Kuusisto J, Lauritzen T, Li M, Lieverse A, Lindgren CM, Lyssenko V, Marre M, Meitinger T, Midthjell K, Morken MA, Narisu N, Nilsson P, Owen KR, Payne F, Petersen AK, Platou C, Proença C, Prokopenko I, Rathmann W, Rayner NW, Robertson NR, Rocheleau G, Roden M, Sampson MJ, Saxena R, Shields BM, Shrader P, Sigurdsson G, Sparsø T, Strassburger K, Stringham HM, Sun Q, Swift AJ, Thorand B, Tichet J, Tuomi T, van Dam RM, van Haeften TW, van Herpt T, van Vliet-Ostaptchouk JV, Walters GB, Weedon MN, Wijmenga C, Witteman J, Bergman RN, Cauchi S, Collins FS, Gloyn AL, Gyllensten U, Hansen T, Hide WA, Hitman GA, Hofman A, Hunter DJ, Hveem K, Laakso M, Morris AD, Palmer CN, Rudan I, Sijbrands E, Stein LD, Tuomilehto J, Uitterlinden A, Walker M, Watanabe RM, Abecasis GR, Boehm BO, Campbell H, Daly MJ, Hattersley AT, Pedersen O, Barroso I, Groop L, Sladek R, Thorsteinsdottir U, Wilson JF, Illig T, Froguel P, van Duijn CM, Stefansson K, Altshuler D, Boehnke M, McCarthy MI, Soranzo N, Wheeler E, Glazer NL, Bouatia-Naji N, Mägi R, Randall J, Elliott P, Rybin D, Dehghan A, Hottenga JJ, Song K, Goel A, Lajunen T, Doney A, Cavalcanti-Proença C, Kumari M, Timpson NJ, Zabena C, Ingelsson E, An P, O'Connell J, Luan J, Elliott A, McCarroll SA, Roccasecca RM, Pattou F, Sethupathy P, Ariyurek Y, Barter P, Beilby JP, Ben-Shlomo Y, Bergmann S, Bochud M, Bonnefond A, Borch-Johnsen K, Böttcher Y, Brunner E, Bumpstead SJ, Chen YD, Chines P, Clarke R, Coin LJ, Cooper MN, Crisponi L, Day IN, de Geus EJ, Delplanque J, Fedson AC, Fischer-Rosinsky A, Forouhi NG, Franzosi MG, Galan P, Goodarzi MO, Graessler J, Grundy S, Gwilliam R, Hallmans G, Hammond N, Han X, Hartikainen AL, Hayward C, Heath SC, Hercberg S, Hillman DR, Hingorani AD, Hui J, Hung J, Kaakinen M, Kaprio J, Kesaniemi YA, Kivimaki M, Knight B, Koskinen S, Kovacs P, Kyvik KO, Lathrop GM, Lawlor DA, Le Bacquer O, Lecoeur C, Li Y, Mahley R, Mangino M, Martínez-Larrad MT, McAteer JB, McPherson R, Meisinger C, Melzer D, Meyre D, Mitchell BD, Mukherjee S, Naitza S, et al. Novel loci for adiponectin levels and their influence on type 2 diabetes and metabolic traits: a multi-ethnic meta-analysis of 45,891 individuals. PLoS Genet. 2012; 8(3):e1002607.

Hodoglugil U, Mahley RW. Turkish population structure and genetic ancestry reveal relatedness among Eurasian populations. Ann Hum Genet. 2012 Mar; 76(2):128-41.

Palmer ND, McDonough CW, Hicks PJ, Roh BH, Wing MR, An SS, Hester JM, Cooke JN, Bostrom MA, Rudock ME, Talbert ME, Lewis JP, Ferrara A, Lu L, Ziegler JT, Sale MM, Divers J, Shriner D, Adeyemo A, Rotimi CN, Ng MC, Langefeld CD, Freedman BI, Bowden DW, Voight BF, Scott LJ, Steinthorsdottir V, Morris AP, Dina C, Welch RP, Zeggini E, Huth C, Aulchenko YS, Thorleifsson G, McCulloch LJ, Ferreira T, Grallert H, Amin N, Wu G, Willer CJ, Raychaudhuri S, McCarroll SA, Langenberg C, Hofmann OM, Dupuis J, Qi L, Segrè AV, van Hoek M, Navarro P, Ardlie K, Balkau B, Benediktsson R, Bennett AJ, Blagieva R, Boerwinkle E, Bonnycastle LL, Boström KB, Bravenboer B, Bumpstead S, Burtt NP, Charpentier G, Chines PS, Cornelis M, Couper DJ, Crawford G, Doney AS, Elliott KS, Elliott AL, Erdos MR, Fox CS, Franklin CS, Ganser M, Gieger C, Grarup N, Green T, Griffin S, Groves CJ, Guiducci C, Hadjadj S, Hassanali N, Herder C, Isomaa B, Jackson AU, Johnson PR, Jørgensen T, Kao WH, Klopp N, Kong A, Kraft P, Kuusisto J, Lauritzen T, Li M, Lieverse A, Lindgren CM, Lyssenko V, Marre M, Meitinger T, Midthjell K, Morken MA, Narisu N, Nilsson P, Owen KR, Payne F, Perry JR, Petersen AK, Platou C, Proença C, Prokopenko I, Rathmann W, Rayner NW, Robertson NR, Rocheleau G, Roden M, Sampson MJ, Saxena R, Shields BM, Shrader P, Sigurdsson G, Sparsø T, Strassburger K, Stringham HM, Sun Q, Swift AJ, Thorand B, Tichet J, Tuomi T, van Dam RM, van Haeften TW, van Herpt T, van Vliet-Ostaptchouk JV, Walters GB, Weedon MN, Wijmenga C, Witteman J, Bergman RN, Cauchi S, Collins FS, Gloyn AL, Gyllensten U, Hansen T, Hide WA, Hitman GA, Hofman A, Hunter DJ, Hveem K, Laakso M, Mohlke KL, Morris AD, Palmer CN, Pramstaller PP, Rudan I, Sijbrands E, Stein LD, Tuomilehto J, Uitterlinden A, Walker M, Wareham NJ, Watanabe RM, Abecasis GR, Boehm BO, Campbell H, Daly MJ, Hattersley AT, Hu FB, Meigs JB, Pankow JS, Pedersen O, Wichmann HE, Barroso I, Florez JC, Frayling TM, Groop L, Sladek R, Thorsteinsdottir U, Wilson JF, Illig T, Froguel P, van Duijn CM, Stefansson K, Altshuler D, Boehnke M, McCarthy MI, Soranzo N, Wheeler E, Glazer NL, Bouatia-Naji N, Mägi R, Randall J, Johnson T, Elliott P, Rybin D, Henneman P, Dehghan A, Hottenga JJ, Song K, Goel A, Egan JM, Lajunen T, Doney A, Kanoni S, Cavalcanti-Proença C, Kumari M, Timpson NJ, Zabena C, Ingelsson E, An P, O'Connell J, Luan J, Elliott A, McCarroll SA, Roccasecca RM, Pattou F, Sethupathy P, Ariyurek Y, Barter P, Beilby JP, Ben-Shlomo Y, Bergmann S, Bochud M, Bonnefond A, Borch-Johnsen K, Böttcher Y, Brunner E, Bumpstead SJ, Chen YD, Chines P, Clarke R, Coin LJ, Cooper MN, Crisponi L, Day IN, de Geus EJ, Delplanque J, Fedson AC, Fischer-Rosinsky A, Forouhi NG, Frants R, Franzosi MG, Galan P, Goodarzi MO, Graessler J, Grundy S, Gwilliam R, Hallmans G, Hammond N, Han X, Hartikainen AL, Hayward C, Heath SC, Hercberg S, Hicks AA, Hillman DR, Hingorani AD, Hui J, Hung J, Jula A, Kaakinen M, Kaprio J, Kesaniemi YA, Kivimaki M, Knight B, Koskinen S, Kovacs P, Kyvik KO, Lathrop GM, Lawlor DA, Le Bacquer O, Lecoeur C, Li Y, Mahley R, Mangino M, Manning AK, Martínez-Larrad MT, McAteer JB, McPherson R, Meisinger C, Melzer D, Meyre D, Mitchell BD, Mukherjee S, Naitza S, Neville MJ, Oostra BA, Orrù M, Pakyz R, Paolisso G, Pattaro C, Pearson D, Peden JF, Pedersen NL, Perola M, Pfeiffer AF, Pichler I, Polasek O, Posthuma D, Potter SC, Pouta A, Province MA, Psaty BM, Rayner NW, Rice K, Ripatti S, Rivadeneira F, Rolandsson O, Sandbaek A, Sandhu M, Sanna S, Sayer AA, Scheet P, Seedorf U, Sharp SJ, Shields B, Sijbrands EJ, Silveira A, Simpson L, Singleton A, Smith NL, Sovio U, Swift A, Syddall H, Syvänen AC, Tanaka T, Tönjes A, Uitterlinden AG, van Dijk KW, Varma D, Visvikis-Siest S, Vitart V, Vogelzangs N, Waeber G, Wagner PJ, Walley A, Ward KL, Watkins H, Wild SH, Willemsen G, Witteman JC, Yarnell JW, Zelenika D, Zethelius B, Zhai G, Zhao JH, Zillikens MC, Borecki IB, Loos RJ, Meneton P, Magnusson PK, Nathan DM, Williams GH, Silander K, et al. A genome-wide association search for type 2 diabetes genes in African Americans. PLoS One. 2012; 7(1):e29202.

Chen HK, Liu Z, Meyer-Franke A, Brodbeck J, Miranda RD, McGuire JG, Pleiss MA, Ji ZS, Balestra ME, Walker DW, Xu Q, Jeong DE, Budamagunta MS, Voss JC, Freedman SB, Weisgraber KH, Huang Y, Mahley RW. Small molecule structure correctors abolish detrimental effects of apolipoprotein E4 in cultured neurons. J Biol Chem. 2012 Feb 17; 287(8):5253-66.

Hodoglugil U, Williamson DW, Yu Y, Farrer LA, Mahley RW. Glucuronic acid epimerase is associated with plasma triglyceride and high-density lipoprotein cholesterol levels in Turks. Ann Hum Genet. 2011 May; 75(3):398-417.

Brodbeck J, McGuire J, Liu Z, Meyer-Franke A, Balestra ME, Jeong DE, Pleiss M, McComas C, Hess F, Witter D, Peterson S, Childers M, Goulet M, Liverton N, Hargreaves R, Freedman S, Weisgraber KH, Mahley RW, Huang Y. Structure-dependent impairment of intracellular apolipoprotein E4 trafficking and its detrimental effects are rescued by small-molecule structure correctors. J Biol Chem. 2011 May 13; 286(19):17217-26.

Chen HK, Ji ZS, Dodson SE, Miranda RD, Rosenblum CI, Reynolds IJ, Freedman SB, Weisgraber KH, Huang Y, Mahley RW. Apolipoprotein E4 domain interaction mediates detrimental effects on mitochondria and is a potential therapeutic target for Alzheimer disease. J Biol Chem. 2011 Feb 18; 286(7):5215-21.

Waterworth DM, Ricketts SL, Song K, Chen L, Zhao JH, Ripatti S, Aulchenko YS, Zhang W, Yuan X, Lim N, Luan J, Ashford S, Wheeler E, Young EH, Hadley D, Thompson JR, Braund PS, Johnson T, Struchalin M, Surakka I, Luben R, Khaw KT, Rodwell SA, Loos RJ, Boekholdt SM, Inouye M, Deloukas P, Elliott P, Schlessinger D, Sanna S, Scuteri A, Jackson A, Mohlke KL, Tuomilehto J, Roberts R, Stewart A, Kesäniemi YA, Mahley RW, Grundy SM, McArdle W, Cardon L, Waeber G, Vollenweider P, Chambers JC, Boehnke M, Abecasis GR, Salomaa V, Järvelin MR, Ruokonen A, Barroso I, Epstein SE, Hakonarson HH, Rader DJ, Reilly MP, Witteman JC, Hall AS, Samani NJ, Strachan DP, Barter P, van Duijn CM, Kooner JS, Peltonen L, Wareham NJ, McPherson R, Mooser V, Sandhu MS. Genetic variants influencing circulating lipid levels and risk of coronary artery disease. Arterioscler Thromb Vasc Biol. 2010 Nov; 30(11):2264-76.

Liu JZ, Tozzi F, Waterworth DM, Pillai SG, Muglia P, Middleton L, Berrettini W, Knouff CW, Yuan X, Waeber G, Vollenweider P, Preisig M, Wareham NJ, Zhao JH, Loos RJ, Barroso I, Khaw KT, Grundy S, Barter P, Mahley R, Kesaniemi A, McPherson R, Vincent JB, Strauss J, Kennedy JL, Farmer A, McGuffin P, Day R, Matthews K, Bakke P, Gulsvik A, Lucae S, Ising M, Brueckl T, Horstmann S, Wichmann HE, Rawal R, Dahmen N, Lamina C, Polasek O, Zgaga L, Huffman J, Campbell S, Kooner J, Chambers JC, Burnett MS, Devaney JM, Pichard AD, Kent KM, Satler L, Lindsay JM, Waksman R, Epstein S, Wilson JF, Wild SH, Campbell H, Vitart V, Reilly MP, Li M, Qu L, Wilensky R, Matthai W, Hakonarson HH, Rader DJ, Franke A, Wittig M, Schäfer A, Uda M, Terracciano A, Xiao X, Busonero F, Scheet P, Schlessinger D, St Clair D, Rujescu D, Abecasis GR, Grabe HJ, Teumer A, Völzke H, Petersmann A, John U, Rudan I, Hayward C, Wright AF, Kolcic I, Wright BJ, Thompson JR, Balmforth AJ, Hall AS, Samani NJ, Anderson CA, Ahmad T, Mathew CG, Parkes M, Satsangi J, Caulfield M, Munroe PB, Farrall M, Dominiczak A, Worthington J, Thomson W, Eyre S, Barton A, Mooser V, Francks C, Marchini J. Meta-analysis and imputation refines the association of 15q25 with smoking quantity. Nat Genet. 2010 May; 42(5):436-40.

Dupuis J, Langenberg C, Prokopenko I, Saxena R, Soranzo N, Jackson AU, Wheeler E, Glazer NL, Bouatia-Naji N, Gloyn AL, Lindgren CM, Mägi R, Morris AP, Randall J, Johnson T, Elliott P, Rybin D, Thorleifsson G, Steinthorsdottir V, Henneman P, Grallert H, Dehghan A, Hottenga JJ, Franklin CS, Navarro P, Song K, Goel A, Perry JR, Egan JM, Lajunen T, Grarup N, Sparsø T, Doney A, Voight BF, Stringham HM, Li M, Kanoni S, Shrader P, Cavalcanti-Proença C, Kumari M, Qi L, Timpson NJ, Gieger C, Zabena C, Rocheleau G, Ingelsson E, An P, O'Connell J, Luan J, Elliott A, McCarroll SA, Payne F, Roccasecca RM, Pattou F, Sethupathy P, Ardlie K, Ariyurek Y, Balkau B, Barter P, Beilby JP, Ben-Shlomo Y, Benediktsson R, Bennett AJ, Bergmann S, Bochud M, Boerwinkle E, Bonnefond A, Bonnycastle LL, Borch-Johnsen K, Böttcher Y, Brunner E, Bumpstead SJ, Charpentier G, Chen YD, Chines P, Clarke R, Coin LJ, Cooper MN, Cornelis M, Crawford G, Crisponi L, Day IN, de Geus EJ, Delplanque J, Dina C, Erdos MR, Fedson AC, Fischer-Rosinsky A, Forouhi NG, Fox CS, Frants R, Franzosi MG, Galan P, Goodarzi MO, Graessler J, Groves CJ, Grundy S, Gwilliam R, Gyllensten U, Hadjadj S, Hallmans G, Hammond N, Han X, Hartikainen AL, Hassanali N, Hayward C, Heath SC, Hercberg S, Herder C, Hicks AA, Hillman DR, Hingorani AD, Hofman A, Hui J, Hung J, Isomaa B, Johnson PR, Jørgensen T, Jula A, Kaakinen M, Kaprio J, Kesaniemi YA, Kivimaki M, Knight B, Koskinen S, Kovacs P, Kyvik KO, Lathrop GM, Lawlor DA, Le Bacquer O, Lecoeur C, Li Y, Lyssenko V, Mahley R, Mangino M, Manning AK, Martínez-Larrad MT, McAteer JB, McCulloch LJ, McPherson R, Meisinger C, Melzer D, Meyre D, Mitchell BD, Morken MA, Mukherjee S, Naitza S, Narisu N, Neville MJ, Oostra BA, Orrù M, Pakyz R, Palmer CN, Paolisso G, Pattaro C, Pearson D, Peden JF, Pedersen NL, Perola M, Pfeiffer AF, Pichler I, Polasek O, Posthuma D, Potter SC, Pouta A, Province MA, Psaty BM, Rathmann W, Rayner NW, Rice K, Ripatti S, Rivadeneira F, Roden M, Rolandsson O, Sandbaek A, Sandhu M, Sanna S, Sayer AA, Scheet P, Scott LJ, Seedorf U, Sharp SJ, Shields B, Sigurethsson G, Sijbrands EJ, Silveira A, Simpson L, Singleton A, Smith NL, Sovio U, Swift A, Syddall H, Syvänen AC, Tanaka T, Thorand B, Tichet J, Tönjes A, Tuomi T, Uitterlinden AG, van Dijk KW, van Hoek M, Varma D, Visvikis-Siest S, Vitart V, Vogelzangs N, Waeber G, Wagner PJ, Walley A, Walters GB, Ward KL, Watkins H, Weedon MN, Wild SH, Willemsen G, Witteman JC, Yarnell JW, Zeggini E, Zelenika D, Zethelius B, Zhai G, Zhao JH, Zillikens MC, Borecki IB, Loos RJ, Meneton P, Magnusson PK, Nathan DM, Williams GH, Hattersley AT, Silander K, Salomaa V, Smith GD, Bornstein SR, Schwarz P, Spranger J, Karpe F, Shuldiner AR, Cooper C, Dedoussis GV, Serrano-Ríos M, Morris AD, Lind L, Palmer LJ, Hu FB, Franks PW, Ebrahim S, Marmot M, Kao WH, Pankow JS, Sampson MJ, Kuusisto J, Laakso M, Hansen T, Pedersen O, Pramstaller PP, Wichmann HE, Illig T, Rudan I, Wright AF, Stumvoll M, Campbell H, Wilson JF, Bergman RN, Buchanan TA, Collins FS, Mohlke KL, Tuomilehto J, Valle TT, Altshuler D, Rotter JI, Siscovick DS, Penninx BW, Boomsma DI, Deloukas P, Spector TD, Frayling TM, Ferrucci L, Kong A, Thorsteinsdottir U, Stefansson K, van Duijn CM, Aulchenko YS, Cao A, Scuteri A, Schlessinger D, Uda M, Ruokonen A, Jarvelin MR, Waterworth DM, Vollenweider P, Peltonen L, Mooser V, Abecasis GR, Wareham NJ, Sladek R, Froguel P, Watanabe RM, Meigs JB, Groop L, Boehnke M, McCarthy MI, Florez JC, Barroso I. New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk. Nat Genet. 2010 Feb; 42(2):105-16.

Richards JB, Waterworth D, O'Rahilly S, Hivert MF, Loos RJ, Perry JR, Tanaka T, Timpson NJ, Semple RK, Soranzo N, Song K, Rocha N, Grundberg E, Dupuis J, Florez JC, Langenberg C, Prokopenko I, Saxena R, Sladek R, Aulchenko Y, Evans D, Waeber G, Erdmann J, Burnett MS, Sattar N, Devaney J, Willenborg C, Hingorani A, Witteman JC, Vollenweider P, Glaser B, Hengstenberg C, Ferrucci L, Melzer D, Stark K, Deanfield J, Winogradow J, Grassl M, Hall AS, Egan JM, Thompson JR, Ricketts SL, König IR, Reinhard W, Grundy S, Wichmann HE, Barter P, Mahley R, Kesaniemi YA, Rader DJ, Reilly MP, Epstein SE, Stewart AF, Van Duijn CM, Schunkert H, Burling K, Deloukas P, Pastinen T, Samani NJ, McPherson R, Davey Smith G, Frayling TM, Wareham NJ, Meigs JB, Mooser V, Spector TD. A genome-wide association study reveals variants in ARL15 that influence adiponectin levels. PLoS Genet. 2009 Dec; 5(12):e1000768.

Li G, Bien-Ly N, Andrews-Zwilling Y, Xu Q, Bernardo A, Ring K, Halabisky B, Deng C, Mahley RW, Huang Y. GABAergic interneuron dysfunction impairs hippocampal neurogenesis in adult apolipoprotein E4 knockin mice. Cell Stem Cell. 2009 Dec 04; 5(6):634-45.

Hodoglugil U, Williamson DW, Mahley RW. Polymorphisms in the hepatic lipase gene affect plasma HDL-cholesterol levels in a Turkish population. J Lipid Res. 2010 Feb; 51(2):422-30.

Mahley RW, Huang Y. Alzheimer disease: multiple causes, multiple effects of apolipoprotein E4, and multiple therapeutic approaches. Ann Neurol. 2009 Jun; 65(6):623-5.

Ling H, Waterworth DM, Stirnadel HA, Pollin TI, Barter PJ, Kesäniemi YA, Mahley RW, McPherson R, Waeber G, Bersot TP, Cohen JC, Grundy SM, Mooser VE, Mitchell BD. Genome-wide linkage and association analyses to identify genes influencing adiponectin levels: the GEMS Study. Obesity (Silver Spring). 2009 Apr; 17(4):737-44.

Mahley RW, Weisgraber KH, Huang Y. Apolipoprotein E: structure determines function, from atherosclerosis to Alzheimer's disease to AIDS. J Lipid Res. 2009 Apr; 50 Suppl:S183-8.

Tanyolaç S, Mahley RW, Hodoglugil U, Goldfine ID. Gender differences in the relationship of ENPP1/PC-1 variants to obesity in a Turkish population. Obesity (Silver Spring). 2008 Nov; 16(11):2468-71.

Tamgüney G, Giles K, Glidden DV, Lessard P, Wille H, Tremblay P, Groth DF, Yehiely F, Korth C, Moore RC, Tatzelt J, Rubinstein E, Boucheix C, Yang X, Stanley P, Lisanti MP, Dwek RA, Rudd PM, Moskovitz J, Epstein CJ, Cruz TD, Kuziel WA, Maeda N, Sap J, Ashe KH, Carlson GA, Tesseur I, Wyss-Coray T, Mucke L, Weisgraber KH, Mahley RW, Cohen FE, Prusiner SB. Genes contributing to prion pathogenesis. J Gen Virol. 2008 Jul; 89(Pt 7):1777-88.

Burt TD, Agan BK, Marconi VC, He W, Kulkarni H, Mold JE, Cavrois M, Huang Y, Mahley RW, Dolan MJ, McCune JM, Ahuja SK. Apolipoprotein (apo) E4 enhances HIV-1 cell entry in vitro, and the APOE epsilon4/epsilon4 genotype accelerates HIV disease progression. Proc Natl Acad Sci U S A. 2008 Jun 24; 105(25):8718-23.

Sandhu MS, Waterworth DM, Debenham SL, Wheeler E, Papadakis K, Zhao JH, Song K, Yuan X, Johnson T, Ashford S, Inouye M, Luben R, Sims M, Hadley D, McArdle W, Barter P, Kesäniemi YA, Mahley RW, McPherson R, Grundy SM, Bingham SA, Khaw KT, Loos RJ, Waeber G, Barroso I, Strachan DP, Deloukas P, Vollenweider P, Wareham NJ, Mooser V. LDL-cholesterol concentrations: a genome-wide association study. Lancet. 2008 Feb 09; 371(9611):483-91.

Brodbeck J, Balestra ME, Saunders AM, Roses AD, Mahley RW, Huang Y. Rosiglitazone increases dendritic spine density and rescues spine loss caused by apolipoprotein E4 in primary cortical neurons. Proc Natl Acad Sci U S A. 2008 Jan 29; 105(4):1343-6.

Mahley RW, Huang Y, Weisgraber KH. Detrimental effects of apolipoprotein E4: potential therapeutic targets in Alzheimer's disease. Curr Alzheimer Res. 2007 Dec; 4(5):537-40.

Stirnadel H, Lin X, Ling H, Song K, Barter P, Kesäniemi YA, Mahley R, McPherson R, Waeber G, Bersot T, Cohen J, Grundy S, Mitchell B, Mooser V, Waterworth D. Genetic and phenotypic architecture of metabolic syndrome-associated components in dyslipidemic and normolipidemic subjects: the GEMS Study. Atherosclerosis. 2008 Apr; 197(2):868-76.

Barter P, McPherson YR, Song K, Kesäniemi YA, Mahley R, Waeber G, Bersot T, Mooser V, Waterworth D, Grundy SM. Serum insulin and inflammatory markers in overweight individuals with and without dyslipidemia. J Clin Endocrinol Metab. 2007 Jun; 92(6):2041-5.

Mahley RW, Huang Y. Atherogenic remnant lipoproteins: role for proteoglycans in trapping, transferring, and internalizing. J Clin Invest. 2007 Jan; 117(1):94-8.

Safar JG, Wille H, Geschwind MD, Deering C, Latawiec D, Serban A, King DJ, Legname G, Weisgraber KH, Mahley RW, Miller BL, Dearmond SJ, Prusiner SB. Human prions and plasma lipoproteins. Proc Natl Acad Sci U S A. 2006 Jul 25; 103(30):11312-7.

Xu Q, Bernardo A, Walker D, Kanegawa T, Mahley RW, Huang Y. Profile and regulation of apolipoprotein E (ApoE) expression in the CNS in mice with targeting of green fluorescent protein gene to the ApoE locus. J Neurosci. 2006 May 10; 26(19):4985-94.

Mahley RW, Huang Y, Weisgraber KH. Putting cholesterol in its place: apoE and reverse cholesterol transport. J Clin Invest. 2006 May; 116(5):1226-9.

Huang Y, Mahley RW. Commentary on "Perspective on a pathogenesis and treatment of Alzheimer's disease." Apolipoprotein E and the mitochondrial metabolic hypothesis. Alzheimers Dement. 2006 Apr; 2(2):71-3.

Mahley RW, Weisgraber KH, Huang Y. Apolipoprotein E4: a causative factor and therapeutic target in neuropathology, including Alzheimer's disease. Proc Natl Acad Sci U S A. 2006 Apr 11; 103(15):5644-51.

Mahley RW, Bersot TP. High density lipoprotein cholesterol in coronary artery patients: is it as low as expected? Anadolu Kardiyol Derg. 2006 Mar; 6(1):94-6; author reply 96.

Hodoglugil U, Mahley RW. Smoking and obesity make a bad problem worse: genetics and lifestyle affect high density lipoprotein levels in Turks. Anadolu Kardiyol Derg. 2006 Mar; 6(1):60-7.

Ye S, Huang Y, Müllendorff K, Dong L, Giedt G, Meng EC, Cohen FE, Kuntz ID, Weisgraber KH, Mahley RW. Apolipoprotein (apo) E4 enhances amyloid beta peptide production in cultured neuronal cells: apoE structure as a potential therapeutic target. Proc Natl Acad Sci U S A. 2005 Dec 20; 102(51):18700-5.

Chang S, ran Ma T, Miranda RD, Balestra ME, Mahley RW, Huang Y. Lipid- and receptor-binding regions of apolipoprotein E4 fragments act in concert to cause mitochondrial dysfunction and neurotoxicity. Proc Natl Acad Sci U S A. 2005 Dec 20; 102(51):18694-9.

Ji ZS, Müllendorff K, Cheng IH, Miranda RD, Huang Y, Mahley RW. Reactivity of apolipoprotein E4 and amyloid beta peptide: lysosomal stability and neurodegeneration. J Biol Chem. 2006 Feb 03; 281(5):2683-92.

Hodoglugil U, Tanyolaç S, Williamson DW, Huang Y, Mahley RW. Apolipoprotein A-V: a potential modulator of plasma triglyceride levels in Turks. J Lipid Res. 2006 Jan; 47(1):144-53.

Mahley RW, Can S, Ozbayrakçi S, Bersot TP, Tanir S, Palaoglu KE, Pépin GM. Modulation of high-density lipoproteins in a population in istanbul, Turkey, with low levels of high-density lipoproteins. Am J Cardiol. 2005 Aug 15; 96(4):547-55.

Yu Y, Wyszynski DF, Waterworth DM, Wilton SD, Barter PJ, Kesäniemi YA, Mahley RW, McPherson R, Waeber G, Bersot TP, Ma Q, Sharma SS, Montgomery DS, Middleton LT, Sundseth SS, Mooser V, Grundy SM, Farrer LA. Multiple QTLs influencing triglyceride and HDL and total cholesterol levels identified in families with atherogenic dyslipidemia. J Lipid Res. 2005 Oct; 46(10):2202-13.

Hodoglugil U, Williamson DW, Huang Y, Mahley RW. Common polymorphisms of ATP binding cassette transporter A1, including a functional promoter polymorphism, associated with plasma high density lipoprotein cholesterol levels in Turks. Atherosclerosis. 2005 Dec; 183(2):199-212.

Wyszynski DF, Waterworth DM, Barter PJ, Cohen J, Kesäniemi YA, Mahley RW, McPherson R, Waeber G, Bersot TP, Sharma SS, Nolan V, Middleton LT, Sundseth SS, Farrer LA, Mooser V, Grundy SM. Relation between atherogenic dyslipidemia and the Adult Treatment Program-III definition of metabolic syndrome (Genetic Epidemiology of Metabolic Syndrome Project). Am J Cardiol. 2005 Jan 15; 95(2):194-8.

Harris FM, Brecht WJ, Xu Q, Mahley RW, Huang Y. Increased tau phosphorylation in apolipoprotein E4 transgenic mice is associated with activation of extracellular signal-regulated kinase: modulation by zinc. J Biol Chem. 2004 Oct 22; 279(43):44795-801.

Xu Q, Brecht WJ, Weisgraber KH, Mahley RW, Huang Y. Apolipoprotein E4 domain interaction occurs in living neuronal cells as determined by fluorescence resonance energy transfer. J Biol Chem. 2004 Jun 11; 279(24):25511-6.

Brecht WJ, Harris FM, Chang S, Tesseur I, Yu GQ, Xu Q, Dee Fish J, Wyss-Coray T, Buttini M, Mucke L, Mahley RW, Huang Y. Neuron-specific apolipoprotein e4 proteolysis is associated with increased tau phosphorylation in brains of transgenic mice. J Neurosci. 2004 Mar 10; 24(10):2527-34.

Huang Y, Weisgraber KH, Mucke L, Mahley RW. Apolipoprotein E: diversity of cellular origins, structural and biophysical properties, and effects in Alzheimer's disease. J Mol Neurosci. 2004; 23(3):189-204.

Bersot TP, Pépin GM, Mahley RW. Risk determination of dyslipidemia in populations characterized by low levels of high-density lipoprotein cholesterol. Am Heart J. 2003 Dec; 146(6):1052-9.

Harris FM, Tesseur I, Brecht WJ, Xu Q, Mullendorff K, Chang S, Wyss-Coray T, Mahley RW, Huang Y. Astroglial regulation of apolipoprotein E expression in neuronal cells. Implications for Alzheimer's disease. J Biol Chem. 2004 Jan 30; 279(5):3862-8.

Harris FM, Brecht WJ, Xu Q, Tesseur I, Kekonius L, Wyss-Coray T, Fish JD, Masliah E, Hopkins PC, Scearce-Levie K, Weisgraber KH, Mucke L, Mahley RW, Huang Y. Carboxyl-terminal-truncated apolipoprotein E4 causes Alzheimer's disease-like neurodegeneration and behavioral deficits in transgenic mice. Proc Natl Acad Sci U S A. 2003 Sep 16; 100(19):10966-71.

Bersot TP, Palaoglu KE, Mahley RW. Managing dyslipidemia in Turkey: suggested guidelines for a population characterized by low levels of high density lipoprotein cholesterol. Anadolu Kardiyol Derg. 2002 Dec; 2(4):315-22.

Shohet RV, Vega GL, Bersot TP, Mahley RW, Grundy SM, Guerra R, Cohen JC. Sources of variability in genetic association studies: insights from the analysis of hepatic lipase (LIPC). Hum Mutat. 2002 May; 19(5):536-42.

Ji ZS, Miranda RD, Newhouse YM, Weisgraber KH, Huang Y, Mahley RW. Apolipoprotein E4 potentiates amyloid beta peptide-induced lysosomal leakage and apoptosis in neuronal cells. J Biol Chem. 2002 Jun 14; 277(24):21821-8.